Hanchung Medical announced that it participated in AMWC Japan 2026 (Aesthetic & Anti-Aging Medicine World Congress Japan 2026), held on September 12 and 13, 2026, at The Prince Park Tower Tokyo in Japan, where it introduced its flagship products to medical professionals from Japan and across Asia.

AMWC is an international scientific congress and exhibition that brings together physicians and companies in the field of aesthetic and anti-aging medicine from around the world. Its Japanese edition, AMWC Japan, serves as a platform for sharing the latest clinical trends and products in medical aesthetics, including fillers, skin boosters, and energy-based devices. Operating Booth A-210 at the event, Hanchung Medical met directly with local physicians, clinic professionals, and distribution partners, closely examining demand and trends in the Japanese medical aesthetics market.

At the exhibition, Hanchung Medical highlighted its key product lineup, including the HA filler Bonetta, the NMN-based skin booster NMN ETELLA, and the high-concentration NAD+ product NovaNAD+. Visitors examined the products firsthand and held consultations on ingredient composition, formulation, and ease of use. Reflecting the strong demand for anti-aging solutions in the Japanese market, the NMN- and NAD+-based product lines drew particularly notable interest.

Through numerous business meetings held during the event, Hanchung Medical discussed potential collaborations with local distributors and clinics in Japan, and plans to expand its supply channels in Japan and other Asian markets based on these discussions.

"AMWC Japan was a meaningful opportunity to see up close how Japanese medical professionals select products and where the market is heading," said a Hanchung Medical representative. "Building on our broad portfolio, from fillers to skin boosters and NAD+ products, we will strengthen trust with local partners and take the next step as a global distribution company that brings Korea's outstanding medical aesthetic products to the world."